Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.

Whyte, Martin B; Shojaee-Moradie, Fariba; Sharaf, Sharaf E; Jackson, Nicola C; Fielding, Barbara; Hovorka, Roman; Mendis, Jeewaka; Russell-Jones, David; Umpleby, A Margot

View / Open Files

Accepted version (PDF, 528Kb)

Authors

Whyte, Martin B

Shojaee-Moradie, Fariba

Sharaf, Sharaf E

Jackson, Nicola C

Fielding, Barbara

Hovorka, Roman

Mendis, Jeewaka

Publication Date

2019-02

Journal Title

The Journal of clinical endocrinology and metabolism

ISSN

0021-972X

Volume

104

Issue

Pages

359-368

Language

eng

Type

Article

This Version

Physical Medium

Metadata

Show full item record

Citation

Whyte, M. B., Shojaee-Moradie, F., Sharaf, S. E., Jackson, N. C., Fielding, B., Hovorka, R., Mendis, J., et al. (2019). Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.. The Journal of clinical endocrinology and metabolism, 104 (2), 359-368. https://doi.org/10.1210/jc.2018-01176

Keywords

Humans, Diabetes Mellitus, Type 2, Blood Glucose, Triglycerides, Chylomicrons, Peptides, Hypoglycemic Agents, Metabolic Clearance Rate, Treatment Outcome, Cross-Over Studies, Double-Blind Method, Gastric Emptying, Postprandial Period, Middle Aged, Male, Glucagon-Like Peptide-1 Receptor

Identifiers

External DOI: https://doi.org/10.1210/jc.2018-01176

This record's URL: https://www.repository.cam.ac.uk/handle/1810/290711

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved